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Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is emerging in Asian 3 countries, China, Japan
and Korea, which are scrub typhus endemic areas, and its incidence is increasing. As the two infections overlap
epidemiologically and clinically and the accessibility or sensitivity of diagnostic tests is limited, early clinical
prediction may be useful for diagnostic and therapeutic purposes.
Methods: Patients aged ≥16 years who were clinically suspected and laboratory-confirmed to be infected with Orientia
tsutsugamushi or the SFTS virus in South Korea were enrolled. Clinical and laboratory parameters were compared. Scrub
typhus was further subclassified according to the status of eschar and skin rash. An SFTS prediction scoring tool was
generated based on a logistic regression analysis of SFTS compared with scrub typhus.
Results: The analysis was performed on 255 patients with scrub typhus and 107 patients with SFTS. At initial
presentation, subjective symptoms except for gastrointestinal symptoms, were more prominent in scrub typhus
patients. In addition to the characteristic eschar and skin rash, headache was significantly more prominent in scrub
typhus, while laboratory abnormalities were more prominent in SFTS. Leukopenia (white blood cell count < 4000/mm3;
odds ratio [OR] 30.13), thrombocytopenia (platelet count < 80,000 /mm3; OR 19.73) and low C-reactive protein
(< 1 mg/dL; OR 67.46) were consistent risk factors for SFTS (all P < 0.001). A prediction score was generated
using these 3 variables, and a score ≥ 2 had a sensitivity of 93.1% (95% confidence interval [CI], 87.9–96.4%)
and a specificity of 96.1% (95% CI, 93.8–97.6%) for SFTS.
Conclusion: This prediction scoring tool may be useful for differentiating SFTS from eschar- or skin rash-negative
scrub typhus. It is a simple and readily applicable tool with potential for use in primary care settings.
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Background
Severe fever with thrombocytopenia syndrome (SFTS) is
an emerging infectious disease that is caused by the SFTS
virus (SFTSV); it is endemic in 3 East Asian countries:
China, Korea and Japan [1–3]. The incidence of SFTS is
increasing, and the case-fatality rate ranges from 5.3 to
32.6% [4–6]; however, there are not yet effective antiviral
therapeutics or a vaccine [7]. SFTS was listed as a priority
disease that requires urgent research and development by
the World Health Organization in 2017 [8]. Orientia
tsutsugamushi is endemic to these 3 countries, which is a
leading cause of treatable non-malarial febrile illness in
Asia [9]. In 2017, 10,528 cases of scrub typhus were re-
ported in South Korea. Eschar and a maculopapular skin
rash are characteristic findings of this disease and are crit-
ical clues for its diagnosis. The case-fatality rate of scrub
typhus has a median of 6.0% in untreated cases and 1.4%
in treated cases [9].
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Although SFTSV and O. tsutsugamushi do not share
specific vectors, they are transmitted to humans through
ticks and mites bites mostly, respectively, during outdoor
activities. The ecological differences between vectors
may characterize their epidemiological features, inclu-
ding the region of infection and peak epidemic seasons.
However, there are considerable overlaps of their epi-
demiological and clinical features, which makes their dif-
ferential diagnosis difficult, particularly during the high
epidemic season of scrub typhus. Patients with SFTS
have the potential to deteriorate during the second week
of the illness [5], and early diagnosis of SFTS may lead
to early investigational therapeutics and stricter infection
control measures to prevent human-to-human transmis-
sion [10–13]. However, the sensitivity of diagnostic assays
for scrub typhus is low [14]. The confirmatory test for
SFTS is usually performed in the national reference la-
boratory, and a serologic assay for the point of care is not
yet commercially available. Therefore, only a high index of
clinical suspicion may lead to a rapid clinical decision or
an early referral, particularly in primary care settings.
Clinical diagnostic prediction based on the features dif-
ferentiating SFTS from scrub typhus in endemic areas,
particularly during the overlap period, may be clinically
useful to guide the diagnostic and therapeutic strategies in
the absence of rapid point-of-care diagnostic test. This
study compared the clinical and laboratory features of the
two diseases and constructed a clinical prediction tool
composed of a scoring system for SFTS. We performed
several subgroup analyses, including for eschar-negative
scrub typhus, which is difficult to suspect clinically
because it lacks critical clues.
Methods
Patients
Patients in South Korea aged ≥16 years who were clini-
cally suspected and laboratory-confirmed to be infected
with O. tsutsugamushi or SFTSV were enrolled. Cases of
eschar-positive and -negative scrub typhus were pro-
spectively included from 8 community-based hospitals
in 2006; part of this study was previously published [15].
Additional patients with only eschar-negative scrub
typhus were prospectively included from 6 community-
based hospitals from 2009 to 2011; these patients had
been thoroughly examined and cared for by the infec-
tious diseases specialists in charge. The participating
hospitals in both studies were Chonbuk National Uni-
versity Hospital, Dankook University Hospital, Dongguk
University Ilsan Hospital, Ilsan Paik Hospital, Namwon
Medical Center, Pusan Paik Hospital, Sanggye Paik Hos-
pital, Sunlin Hospital, Boramae Medical Center, and
Wonkwang University Hospital. SFTS cases were retro-
spectively collected from 36 hospitals nationwide from
2013 to 2015. Part of this study was previously published
[5], and part of the hospitals are listed in the Acknow-
ledgements section.
Scrub typhus was confirmed either by eschar- or buffy
coat-based polymerase chain reaction (PCR) or by a
serologic assay. PCR targeting the variable domains I
and II of the 56-kDa antigen gene of O. tsutsugamushi
was performed using a set of primers (forward: TTT
CGA ACG TGT CTT TAA GC; reverse: ACA GAT
GCA CTA TTA GGC AA; 1151 bp); the products were
sequenced to match the reference genotypes, as de-
scribed in a previous study [15]. The presence of four-
fold or greater changes in the titers of the paired sera
from an indirect immunofluorescence antibody assay
(IFA) or a passive hemagglutination assay (GreenCross
SangA; Yongin city, South Korea) was used as the posi-
tive serologic criteria. All sera from patients with con-
firmed scrub typhus were screened for the co-infection
with SFTSV. SFTS is a reportable infectious disease to
the Korea Centers for Disease Control and Prevention
(KCDC) and all SFTSV infections were confirmed at the
KCDC by detecting the M segment gene of the SFTSV
RNA using one-step reverse transcription (RT)-PCR as
described in a previous study [16].
Study design
Baseline characteristics and clinical and laboratory parame-
ters were compared between scrub typhus and SFTS to de-
termine the differentiating factors. Scrub typhus was
further subclassified into eschar-negative and -positive
groups for comparison with SFTS. An SFTS prediction
scoring tool was generated based on logistic regression
analysis for SFTS. The baseline characteristics included
demographic variables, comorbidities, site of infection, sea-
son of infection, duration from the onset of illness to first
visit, duration of the hospital stay, and in-hospital morta-
lity. The clinical parameters included commonly known
symptoms and signs of both diseases such as headache,
altered consciousness, cough, dyspnea, gastrointestinal
manifestations, skin rash and the presence of a bite wound.
The laboratory parameters included a complete blood
count and chemistry, which can be easily obtained in pri-
mary care settings as a point-of-care testing. The worst
values of the clinical and laboratory parameters within 24 h
of the initial visit were used. The frequency of major com-
plications during the clinical course was also compared.
Altered mentality was defined as a Glasgow coma scale
score < 15. Acute kidney injury was defined as serum
creatinine levels ≥2.0 mg/dL and 1.5 times the base-
line level [17]. Shock was defined as a mean arterial
pressure < 65 mmHg. The categorical cut-offs for the
comparison of some laboratory values such as
thrombocytopenia (platelet count < 80,000 /mm3), as-
partate transaminase (AST) ≥400 IU/L and alanine
transaminase (ALT) ≥200 IU/L were chosen in view of
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their mean values in SFTS cases and their kinetics during
the clinical course, as shown in a previous study [5]. Geo-
graphic location was divided into the western and eastern
areas of South Korea. The western area included the Seoul
metropolitan area and Gyeonggi, Chungcheong and Cholla
provinces, which mostly consist of plain rice fields. The
eastern area included Kangwon and Gyeongsang provinces,
which mostly consist of hilly and mountainous areas.
Statistical analysis
Chi-square or Fisher’s exact tests were used to analyze the
categorical variables. T-tests or Mann-Whitney U-tests
were used to compare the continuous variables. A multi-
variate logistic regression analysis was performed using
the risk factors that were significantly (P < 0.05) associated
with SFTS or scrub typhus in the univariate analysis and
adjusted with the duration from the onset of illness to the
initial presentation. The SFTS prediction scoring tool was
generated using the logistic regression analysis for estimat-
ing odds ratios. The receiver operating characteristic curve
was constructed for the scoring model (SPSS v20.0,
Armonk, NY: IBM Corp.).
Results
A total of 362 patients were included in the analysis, in-
cluding 255 patients with scrub typhus and 107 patients
with SFTS. Eschar-positive scrub typhus accounted for
80.4% (205/255) and eschar-negative scrub typhus for
19.6% (50/255) of patients. Scrub typhus was confirmed
by PCR in 153 patients and by serology in 102 patients.
All patients with scrub typhus (N = 255) showed negative
results for SFTSV in the sera. Compared to scrub typhus
patients, patients with SFTS showed a higher median age
(71 years), more comorbidities such as diabetes mellitus
and hypertension, a greater tendency toward infection in
the summer season, a greater tendency to be infected in
the eastern area of South Korea, a shorter duration from
the onset of illness to the first visit (median of 4 days), a
longer duration of hospital stay (median of 10 days), and a
higher case-fatality rate (40.2% vs 0.4%, respectively)
(Table 1).
At the initial presentation, the overall subjective symp-
toms, except for gastrointestinal symptoms, were more
prominent in patients with scrub typhus. Skin rash was
predominantly present in scrub typhus cases (87.8 and
78.0% in eschar-positive and -negative scrub typhus re-
spectively, vs 5.7% in SFTS). Bite wounds were present
in 28.3% of SFTS patients. Altered mentality was more
common in SFTS patients (27.9%). In the subgroup
comparisons, patients with eschar-negative scrub typhus
presented fewer subjective symptoms. Fever was present
in all the patients and was the initial chief problem lea-
ding to a hospital visit. The presence of skin rash
(78.0%) in eschar-negative scrub typhus was similar to
the rate in eschar-positive scrub typhus (P = 0.110)
(Table 2). Laboratory abnormalities were more prominent
in SFTS. Leukopenia, thrombocytopenia, and an elevation
of AST and lactate dehydrogenase (LDH) were more com-
mon in SFTS. C-reactive protein (CRP) was rarely elevated
in SFTS (mean 1.24mg/dL) (Table 3). SFTS was asso-
ciated with a disproportionately higher incidence of major
complications during the hospitalization course such as
decreased mentality (59.0%), seizure (16.2%), pneumonia
(74.4%), the need for mechanical ventilation (32.1%), and
acute kidney injury (21.5%) (Table 4).
In the multivariate regression analysis, leukopenia
(white blood cell count < 4000/mm3; odds ratio [OR] 30.13,
P < 0.001), thrombocytopenia (platelet count < 80,000/mm3;
OR 19.73, P < 0.001) and low CRP (< 1 mg/dL; OR
67.46, P < 0.001) were significantly predictive factors for
SFTS compared with scrub typhus (Table 5). These 3
factors were consistently significant in a subgroup ana-
lysis compared with eschar-negative scrub typhus. As
few laboratory results were significantly indicative of
scrub typhus in comparison with SFTS in the univariate
analysis, primarily only clinical variables were included
in the multivariate analysis to identify the predictive
factors for scrub typhus. In addition to the characteris-
tic eschar and skin rash, headache was the only consis-
tent risk factor for all cases of scrub typhus and the
subgroup of eschar-negative scrub typhus.
A prediction scoring tool for the differential diagnosis of
SFTS and scrub typhus was generated using the combi-
nation of those 3 parameters (1 point each for WBC count
< 4000/mm3, platelet count < 80,000/mm3 and CRP value
< 1mg/dL); the total score ranged from 0 to 3. On the
ROC curve obtained for this model, the optimal cut-off
was ≥2. A score ≥ 2 had a sensitivity of 93.1% (95% confi-
dence interval [CI], 87.9–96.4%) and a specificity of 96.1%
(95% CI, 93.8–97.6%) for SFTS, with an ROC area under
the curve of 0.972 (95% CI, 0.952–0.990) (Table 6). In the
eschar-negative scrub typhus subgroup, a score ≥ 2 had a
sensitivity of 93.1% (95% CI, 88.9–95.2%) and a specificity
of 93.9% (95% CI, 85.0–98.3%) for SFTS. In the subgroup
of rash-negative scrub typhus, a score ≥ 2 had a sensitivity
of 93.1% (95% CI, 89.0–95.2%) and a specificity of 90.3%
(95% CI, 76.8–97.2%) for SFTS (Table 6).
Discussion
A considerable number of SFTS cases occur during the
epidemic season of scrub typhus in South Korea. In 2017,
86.7% (9132/10,528) of scrub typhus and 48.1% (131/272)
of SFTS cases were officially reported to occur from Sep-
tember to November. Although the case-fatality rate of
scrub typhus is low with antibiotic treatment, severe scrub
typhus remains an unresolved issue [18, 19]. The concur-
rent presence of the typical eschar with a compatible cli-
nical manifestation makes the clinical diagnosis of scrub
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typhus obvious [20], but the poor sensitivity of diagnostic
assays for scrub typhus and the presence of eschar-nega-
tive scrub typhus make the diagnosis uncertain in some
patients. Given this diagnostic uncertainty combined with
the potential of severe clinical form, a clinical prediction
tool will be very useful to narrow the differential diagnosis
for those requiring further urgent investigation [14].
Our prediction tool used 3 variables; leukopenia
(WBC count < 4000/mm3), thrombocytopenia (platelet
count < 80,000/mm3) and low CRP (< 1 mg/dL), which
could be obtained from routine basic laboratory blood
tests and are readily applicable in primary care settings.
The cut-off level of thrombocytopenia as platelet count
of 80,000/mm3 was determined by considering the
distribution of platelet counts among the study subjects
and the kinetics of initially persistent thrombocytopenia
in SFTS [5]. One study previously proposed a similar
scoring system using 4 variables: altered mental status,
leukopenia, prolonged activated partial thromboplastin
time and normal C-reactive protein [21]. In our study,
‘altered mental status’ was not a significant factor to be
incorporated into the prediction analysis. We objec-
tively assessed mental status using the Glasgow coma
scale, which is one of the basic tools used in critical
care. We did not include the coagulation panels in the
initial comparison because we do not routinely check
coagulation panels during the investigation of possible
scrub typhus cases.
A larger sample size might have led to different re-
sults. Our study also included a relatively larger num-
ber of eschar-negative scrub typhus cases, which causes
diagnostic challenges and requires a clinical decision to
guide further diagnostic evaluations. We adjusted the
comparison with the duration from the onset of illness
to the initial presentation because the kinetics of clin-
ical variables are closely time-dependent. The predic-
tion tool worked similarly in all subgroups of scrub
typhus (Table 6). The data collection from multiple
Table 1 Baseline characteristics of the subjects (n = 362)




valuebn = 205 n = 50 n = 107
Age, years (median, IQR) 60 (49–71) < 0.001 64.5 (51.2–70.7) 0.004 71 (61–78) < 0.001
Male gender, n (%) 81 (39.5) 0.044 22 (44.0) 0.387 55 (51.4) 0.054
Comorbidity
Diabetes mellitus 19 (9.3) 0.027 5 (10.0) 0.200 19/106 (17.9) 0.023
Hypertension 44 (21.5) 0.030 13 (26.0) 0.395 35 (32.7) 0.039
CVA 7 (3.4) 1.000 1 (2.0) 1.000 4 (3.7) 0.771
Congestive heart failure 9 (4.4) 0.342 2 (4.0) 0.593 2 (1.9) 0.254
Chronic liver disease 7 (3.4) 0.272 5 (10.0) 0.013 1 (0.9) 0.119
Asthma/COPD 7 (3.4) 0.583 1 (2.0) 0.665 5 (4.7) 0.474
Solid tumor 6 (2.9) 0.098 2 (4.0) 0.098 0 0.111
None 126 (61.5) 0.121 26 (52.0) 0.969 56 (52.3) 0.202
Seasonal occurrence, n (%)
Spring-summer (Mar-Aug) 0 < 0.001 0 < 0.001 67 (62.6) < 0.001
Autumn (Sep-Dec) 205 (100) 50 (100) 40 (37.4)
Geographical location
Western area 167 (81.5) < 0.001 42 (84.0) < 0.001 36/104 (34.6) < 0.001
Eastern area 38 (18.5) 8 (16.0) 68/104 (65.4)
Duration, mean (±SD), days
From onset of illness to admission 6.63 (3.918) < 0.001 6.38 (5.103) 0.006 4.39 (3.66)) < 0.001
Hospital stay 6.26 (11.927) < 0.001 6.18 (3.757) < 0.001 12.07 (9.57) < 0.001
Mortality, in-hospital 1 (0.5) < 0.001 0 < 0.001 43 (40.2) < 0.001
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, IQR interquartile range, SD standard deviation, CVA cerebrovascular accident, COPD chronic
obstructive lung disease
aP value when compared to SFTS
bP value when compared to SFTS
cP value when compared to all scrub typhus
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hospitals in major endemic areas of the two diseases
might strengthen the generalizability of our study.
In a binary comparison of clinical parameters, scrub
typhus tended to present with more subjective manifes-
tations, whereas SFTS showed more laboratory abnor-
malities. In a subgroup comparison of eschar-negative
scrub typhus with SFTS, skin rash and headache were
significantly indicative of scrub typhus. As the skin rash
in scrub typhus is a characteristic maculopapular type
that is clinically distinct from that of SFTS [20], the
presence of a maculopapular skin rash itself has diagnos-
tic value if the clinician is sufficiently experienced. How-
ever, approximately 10% of patients with scrub typhus
are reported to lack the typical skin rash [22, 23]. There-
fore, scrub typhus without eschar and a skin rash poses
a further diagnostic challenge. In our study, 12.2% of
eschar-positive and 22.0% of eschar-negative scrub
typhus patients had no skin rash. The rate of eschar-
negative scrub typhus has been reported to be approxi-
mately 10%, although a skilled physician may observe a
different rate [22, 23].
Reports regarding co-infection of both scrub typhus and
SFTS are limited. In a recent report, 23.0% of patients
clinically suspected of scrub typhus were SFTS-positive
[24]. There was a case report of co-infection diagnosed by
PCR [25]. In another report, however, none of the 38
patients with scrub typhus were SFTS-positive, whereas
one of 21 patients with SFTS was serologically suggestive
of scrub typhus. Thus, the clinical evidence on the
possibility of co-infection is not solid, and further moni-
toring is necessary. From an ecological perspective, given
the vectors of the two diseases, co-infection is not likely.
Although the epidemic seasons overlap and there is a risk
of simultaneously acquiring the two diseases during out-
door activity, they do not share vectors, and the ecologies
of their vectors differs. Phenotypically, scrub typhus is
highly prevalent in the rice field areas of western and
southwestern South Korea [26], whereas the incidence of
SFTS is low in this area, consistent with the low SFTSV
infection rate in ticks. Conversely, the incidence of SFTS
is high in the eastern and southeastern mountainous area
of South Korea [5, 27].
The causative agent of scrub typhus, O. tsutsugamushi,
is transmitted by trombiculid chigger mites. The causative
Trombiculidae have a nationwide distribution in South
Korea [28, 29]. Although the larvae of trombiculid mites
can parasitize most animals, rodents and some other small
mammals are their primary hosts [30, 31]. The prevalence
and abundance of chigger mites on small mammals are
much higher in cultivated flatland landscapes [32]. Mean-
while, Haemaphysalis longicornis is the predominant
vector for SFTSV, but other tick species such as H. flava,
Amblyomma testudinarium and Ixodes nipponensis can
also carry SFTSV in South Korea [27, 33, 34]. H.
longicornis is able to transmit SFTSV via both transo-
varial and transstadial modes [35]. H. longicornis is
widely distributed in Australia, New Zealand, Korea, Japan
and China [36]. Larger mammals, such as rabbits, badgers,
Table 2 Clinical symptom and sign at the initial presentation (n = 362)






n = 205 n = 50
Fever 205 (100) < 0.001 50 (100) 0.017 95/106 (89.6) < 0.001
Headache 179 (87.3) < 0.001 30 (60.0) < 0.001 26/105 (24.8) < 0.001
Myalgia 172 (83.9) < 0.001 29 (58.0) 0.794 58/104 (55.8) < 0.001
Conjunctival injection 78 (38.0) < 0.001 6 (12.0) 0.215 6/98 (6.1) < 0.001
Sore throat 74 (36.1) < 0.001 11 (22.0) 0.005 7/105 (6.7) < 0.001
Cough 76 (37.1) < 0.001 15 (30.0) 0.004 12/105 (11.4) < 0.001
Dyspnea 47 (22.9) 0.004 9 (18.0) 0.138 10/104 (9.6) 0.006
Nausea/vomiting 81 (39.5) 0.463 14 (28.0) 0.370 37/105 (35.2) 0.718
Abdominal pain 58 (28.3) 0.019 9 (18.0) 0.778 17/105 (16.2) 0.033
Arthralgia 62 (30.2) < 0.001 4 (8.0) 0.429 5/104 (4.8) < 0.001
Skin rash 180 (87.8) < 0.001 39 (78.0) < 0.001 6/105 (5.7) < 0.001
Presence of bite wound 205 (100) < 0.001 0 (0) < 0.001 30/106 (28.3) < 0.001
Altered mentality 11 (5.4) < 0.001 5 (10.0) 0.012 29/104 (27.9) < 0.001
Shock (MAP < 65mmHg) 15 (7.3) 0.085 4 (8.0) 0.427 14/105 (13.3) 0.079
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, MAP mean arterial pressure
aP value when compared to SFTS
bP value when compared to SFTS
cP value when compared to all scrub typhus
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deer and wild boars, rather than rodents, have been sug-
gested to be the principal hosts for this tick species [36].
The differences between the main hosts and habitats of
the vectors makes their simultaneous exposure less likely.
However, the enhanced intrusion of wild animals into cul-
tivated farmland areas and serologic evidence of SFTSV
infection in domestic animals may indicate the exposure
risk to dual vectors [37, 38]. The case-fatality trend of
scrub typhus also deserves to be mentioned for indirect
evidence of co-infection. Although there are approxi-
mately 10,000 cases of scrub typhus annually in South
Korea, the recent annual mortality was stable in the range
Table 3 Laboratory findings at the initial presentation (n = 362)






n = 205 n = 50
White blood cells, /mm3 6909 ± 3755 < 0.001 8426 ± 4207 < 0.001 2317 ± 1930 < 0.001
Leukopenia (< 4000/mm3), % 42 (20.5) < 0.001 5 (10.0) < 0.001 97/106 (91.5) < 0.001
Hemoglobin, g/dL 12.8 ± 1.8 0.007 12.1 ± 1.6 < 0.001 13.4 ± 1.7 0.001
Anemia (< 11 g/dL) 22 (10.7) 0.532 11 (22.0) 0.019 9/106 (8.5) 0.230
Platelet (×103/mm3) 133 ± 47 < 0.001 161 ± 89 < 0.001 61 ± 30 < 0.001
Thrombocytopeniad, % 21 (10.2) < 0.001 5 (10.0) < 0.001 83/106 (78.3) < 0.001
Serum albumin, d/dL 3.5 ± 0.6 0.575 3.07 ± 0.59 0.031 3.4 ± 0.6 0.851
Total bilirubin, mg/dL 0.93 ± 1.14 < 0.001 0.64 ± 0.66 0.034 0.40 ± 0.61 < 0.001
AST, IU/L 108 ± 107 < 0.001 170 ± 277 0.007 381 ± 505 < 0.001
≥ 400 IU/L 4/204 (2.0) < 0.001 4 (8.0) 0.001 33/106 (31.1) < 0.001
ALT, IU/L 96 ± 108 0.026 138 ± 192 0.824 131 ± 159 0.135
≥ 200 IU/L 16/204 (7.8) 0.002 9 (18.0) 0.789 21/106 (19.8) 0.010
Lactate dehydrogenase, IU/L 700 ± 423 < 0.001 761 ± 393 0.014 1615 ± 2159 < 0.001
≥ 800 IU/L 48/183 (26.2) < 0.001 14/40 (35.0) 0.021 55/97 (56.7) < 0.001
Serum creatinine, mg/dL 1.04 ± 0.63 0.634 1.14 ± 0.70 0.567 1.08 ± 0.51 0.841
≥ 2.0 mg/dL 5/203 (2.5) 1.000 4 (8.0) 0.086 2/105 (1.9) 0.519
Hypokalemia (< 3.5 mmol/L) 52/204 (25.5) 0.155 12/49 (24.5) 0.372 19/104 (18.3) 0.153
C-reactive protein, mg/dL 7.27 ± 5.50 < 0.001 9.82 ± 7.41 < 0.001 1.24 ± 2.64 < 0.001
< 1mg/dL 7/182 (3.8) < 0.001 1/49 (2.0) < 0.001 66/102 (64.7) < 0.001
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, AST aspartate aminotransferase, ALT alanine aminotransferase
aP value when compared to SFTS
bP value when compared to SFTS
cP value when compared to all scrub typhus
dThrombocytopenia, < 80 × 103 /mm3
Table 4 Major complications during the clinical course (n = 362)






n = 205 n = 50
CNS involvement
Altered mentality (GCS < 15) 14/199 (7.0) < 0.001 8 (16.0) < 0.001 62/105 (59.0) < 0.001
Seizure 0/199 (0) < 0.001 0 (0) 0.002 17/105 (16.2) < 0.001
Lung involvement
Mechanical ventilation 5 (2.4) < 0.001 2 (4.0) < 0.001 34/106 (32.1) < 0.001
Renal involvement
Acute kidney injury 5 (2.4) < 0.001 5 (10.0) 0.080 23 (21.5) < 0.001
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, CNS central nervous system, GCS Glasgow coma scale
aP value when compared to SFTS
bP value when compared to SFTS
cP value when compared to all scrub typhus
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of 11–13 cases (http://www.cdc.go.kr/npt). This suggests
that co-infection is rare, considering the high mortality
and rising incidence of SFTS.
The magnitude of the prevalence of SFTS and the need
for intense differential vigilance in the community must
be further investigated. The seroprevalence for SFTSV
antibodies in South Korea were reported to be 2.7 to 7.7%
in rural area and 1.9% in urban areas in small-scale studies
[39, 40]. SFTS is already endemic throughout South
Korea, and the rapidly increasing trend of its incidence is
obvious [5]. The severity and poor prognosis of SFTS de-
mand accurate initial clinical triage. Human granulocytic
anaplasmosis and human monocytotrophic ehrlichiosis
which have similar clinical presentations are also import-
ant differential diseases. Hence, we suggest a clinical deci-
sion algorithm based on our findings as follows. In an
atypical febrile disease during the epidemic season of
scrub typhus, the empirical administration of doxycycline
is desirable. Positive findings of eschar or a maculopapular
skin rash on physical examination are strongly suggestive
of scrub typhus and are an indication for maintaining
doxycycline treatment. If there is no eschar or maculopa-
pular rash, the calculation of the prediction score in our
study may guide the degree of suspicion for SFTS. Until
confirming the presence of SFTS, continuing doxycycline
may be clinically useful to cover eschar- and skin rash-
negative scrub typhus, anaplasmosis, and ehrlichiosis,
which all respond to doxycycline.
This study has several limitations. First, the prediction
scoring tool was evaluated only in comparison with scrub
typhus. Further performance assessment in general febrile
patients may be useful to demonstrate the utility of this
tool for clinically identifying SFTS. Second, although the
SFTS data were primarily obtained from intensive clinical
care settings, the retrospective nature of data collection
might lead to a bias in contrast to the prospective collec-
tion of scrub typhus cases. In addition, only viremic SFTS
cases were included, which might exclude mild cases.
Table 6 Diagnostic performance of the SFTS prediction scoring system
SFTS score Sensitivity (95% CI) Specificity (95% CI) Positive likelihood ratio (95% CI) Negative likelihood ratio (95% CI)
A. SFTS vs. eschar-positive and -negative scrub typhus
≥2 0.931 (0.879–0.964) 0.961 (0.938–0.976) 23.905 (14.211–39.547) 0.071 (0.037–0.128)
3 0.422 (0.376–0.431) 0.996 (0.976–1.000) 97.382 (15.379–1903.086) 0.581 (0.569–0.640)
B. SFTS vs. eschar-negative scrub typhus
≥2 0.931 (0.889–0.952) 0.939 (0.850–0.983) 15.212 (5.925–54.850) 0.073 (0.048–0.131)
3 0.422 (0.382–0.422) 1.000 (0.918–1.000) NA 0.578 (0.578–0.673)
C. SFTS vs. rash-negative scrub typhus
≥2 0.931 (0.890–0.952) 0.903 (0.768–0.972) 9.624 (3.836–34.539) 0.076 (0.049–0.143)
3 0.422 (0.384–0.422) 1.000 (0.875–1.000) NA 0.578 (0.578–0.705)
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, CI confidence interval, NA not available
Table 5 Multivariate analysis for the predictive factors of SFTS compared to those of eschar-positive and negative scrub typhus
Variables Odds ratio (95% CI) P value
Age 1.03 (0.98–1.09) 0.145
Male gender 2.09 (0.58–7.44) 0.255
Diabetes mellitus 2.53 (0.36–17.43) 0.345
Hypertension 0.64 (0.12–3.28) 0.593
Duration, from onset of illness to initial visit 0.80 (0.68–0.94) 0.008
Altered mentality 2.31 (0.27–19.33) 0.439
Shock 1.72 (0.23–12.68) 0.592
Leukopenia (WBC < 4000/mm3) 30.13 (6.08–149.22) < 0.001
Thrombocytopenia (< 80,000/mm3) 19.73 (4.60–84.58) < 0.001
AST ≥400 IU/L 8.33 (0.39–176.07) 0.173
ALT ≥200 IU/L 0.36 (0.03–4.07) 0.411
LDH ≥800 IU/L 3.05 (0.65–14.15) 0.154
C-reactive protein < 1mg/dL 67.46 (14.29–318.30) < 0.001
Abbreviations: SFTS severe fever with thrombocytopenia syndrome, CI confidence interval, WBC white blood cell, AST aspartate aminotransferase, ALT alanine
aminotransferase, LDH lactate dehydrogenase
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However, our concentration on moderate to severe
cases might have greater clinical impacts in practice.
Third, we did not evaluate other parameters such as ac-
tivated partial thromboplastin time or ferritin, which
have also been suggested as useful markers for SFTS,
because the previous scrub typhus studies did not in-
clude those variables [21, 41]. However, these labora-
tory variables are not readily available at a point of care
or are not necessary for usual clinical practices in the
primary care settings where the confirmatory assays for
both diseases are not available. Lastly, we used several
cohorts of different time points. As there is no evidence
that the clinical features of scrub typhus and SFTS have
changed respectively, and we have used a same meth-
odology, mixing of cohorts might not lead to the sig-
nificant inhomogeneity.
Conclusions
We suggested a clinical prediction scoring tool for SFTS in
comparison with scrub typhus that consists of 3 variables:
leukopenia (WBC count < 4000/mm3), thrombocytopenia
(platelet count < 80,000/mm3) and low CRP (< 1mg/dL). It
is a simple and readily applicable tool that can be used in
primary care settings. It will be useful for differentiating
between SFTS and eschar- and skin rash-negative scrub
typhus. We also showed an in-depth comparison of SFTS
and scrub typhus to better understand the clinical features
of both diseases. This tool may also be used to screen out
SFTS in areas where SFTS has not yet been reported but is
geographically capable of existing because of proximity to
the endemic countries.
Abbreviations
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